Ceftriaxone is indicated for the treatment of the following infections caused by susceptible strains of the microorganisms. Lower Respiratory Tract Infections: Caused by E.coli, H.influenzae, K. pneumoniae and species, S. aureus, S. pneumoniae and species (excluding enterococci). Urinary tract Infections (complicated and uncomplicated): Caused by E. coli, Klebsiella species P. mirabilis and Pvulgaris. Bacterial Septicemia: Caused by E. coli, H influenzae, K. pneumoniae, S aureus and S pneumoniae. (excluding enterococci). Skin and Skin Structure Infections : Caused by K. pneumoniae and species, P. irabilis, S.aureus, S. epidermidis and Streptococcus species (excluding enterococci). Bone and Joint Infections: Caused by S. aureus,S.
pneumoniae and Streptococcus species (excluding enterococci). Intra-Abdominal Infections: Caused by E.coli and K. pneumonia.
Meningitis: Caused by H. influenzae, N. meningitidis, and S. pneumoniae. Ceftnaxone should not be used for the treatment of meningitis caused by L. moriocytogenes. Uncomplicated Gonorrhea (cervical/urethral, pharyngeal and rectal): Caused by N. gonorrhoea (penicillinase and nonpenicillinase producing strains). Prophylaxis: The preoperative administration of a single
1g dose of ceftriaxone may reduce the incidence of postoperative infections in patients undergoing vaginal or abdominal hysterectomy, coronary artery bypass surgery or in patients at risk of infection undergoing biliary tract surgery. If signs of post surgical infection appear, specimens for culture should be obtained for identification of the causative organism (s) so that the appropriate therapy may be instituted.Known allergy to cettriaxone, other cephalosporins or penicilliris.
Dosage Forms:
Each vial contains:
Ceftriaxone 250mg as sterile Ceftriaxone sodium USP in powder form. Cefotrim-500 Injection
Each vial contains:
Ceftriaxone 500mg as sterile Ceftriaxone sodium USP in powder form. Cefotrim-1 000 Injection
Each vial contains:
Ceftriaxone 1000mg as sterile Ceftriaxone sodium USP in powder form.